3 February 2021 - Switzerland’s medical regulator has said it cannot authorise use of the Oxford/AstraZeneca Covid-19 vaccine based on the available trial data, a further setback for the rollout of the Anglo-Swedish jab.
The vaccine, which is already being administered in the UK, was given authorisation for use across the EU last Friday, but health officials in France, Germany, Italy, Sweden and Poland have advised against its use for older people. Switzerland, which is not a member of the EU, is the first European country to rule against approving the jab.